TREM2 and Alzheimer disease: Considering that no animal model fully mimics the AD related pathologies and 5xFAD mice merely develop amyloid pathology which recapitulates the very early stage of AD [71], our current data cannot address how TREM2 p.H157Y affects late-stage AD pathologies including tauopathy and neurodegeneration.